Animal models and therapeutic molecular targets of cancer: utility and limitations M Cekanova, K Rathore Drug design, development and therapy, 1911-1922, 2014 | 315 | 2014 |
Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis K Rathore, S Choudhary, A Odoi, HCR Wang Carcinogenesis 33 (1), 174-183, 2012 | 67 | 2012 |
Grape seed proanthocyanidin suppression of breast cell carcinogenesis induced by chronic exposure to combined 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone and benzo [a] pyrene X Song, N Siriwardhana, K Rathore, D Lin, HCR Wang Molecular Carcinogenesis: Published in cooperation with the University of …, 2010 | 55 | 2010 |
Molecular Imaging of Cyclooxygenase-2 in Canine Transitional Cell Carcinomas In Vitro and In Vivo M Cekanova, MJ Uddin, JW Bartges, A Callens, AM Legendre, K Rathore, ... Cancer Prevention Research 6 (5), 466-476, 2013 | 46 | 2013 |
Piroxicam inhibits Masitinib-induced cyclooxygenase 2 expression in oral squamous cell carcinoma cells in vitro K Rathore, M Alexander, M Cekanova Translational Research 164 (2), 158-168, 2014 | 43 | 2014 |
Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens K Rathore, HCR Wang Molecular carcinogenesis 51 (3), 280-289, 2012 | 42 | 2012 |
Inhibition of the PI3K/AKT pathway sensitizes oral squamous cell carcinoma cells to anthracycline‐based chemotherapy in vitro D Smolensky, K Rathore, J Bourn, M Cekanova Journal of cellular biochemistry 118 (9), 2615-2624, 2017 | 41 | 2017 |
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer D Smolensky, K Rathore, M Cekanova Drug Design, Development and Therapy, 3305-3322, 2016 | 38 | 2016 |
Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells S Choudhary, K Rathore, HCR Wang Journal of cancer research and clinical oncology 137, 471-480, 2011 | 31 | 2011 |
Aligned nanofiber material supports cell growth and increases osteogenesis in canine adipose‐derived mesenchymal stem cells in vitro S Pandey, K Rathore, J Johnson, M Cekanova Journal of Biomedical Materials Research Part A 106 (7), 1780-1788, 2018 | 25 | 2018 |
Animal model of naturally occurring bladder cancer: characterization of four new canine transitional cell carcinoma cell lines K Rathore, M Cekanova BMC cancer 14, 1-10, 2014 | 24 | 2014 |
Evaluation of the role of the cyclooxygenase signaling pathway during inflammation in skin and muscle tissues of ball pythons (Python regius) RA Sadler, JP Schumacher, K Rathore, KM Newkirk, G Cole, R Seibert, ... American journal of veterinary research 77 (5), 487-494, 2016 | 23 | 2016 |
Mesenchymal and stem-like cell properties targeted in suppression of chronically-induced breast cell carcinogenesis K Rathore, HCR Wang Cancer letters 333 (1), 113-123, 2013 | 22 | 2013 |
Spo0B of Bacillus anthracis–a protein with pleiotropic functions AR Mattoo, M Saif Zaman, GP Dubey, A Arora, A Narayan, N Jailkhani, ... FEBS Journal 275 (4), 739-752, 2008 | 18 | 2008 |
Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro D Smolensky, K Rathore, M Cekanova BMC cancer 15, 1-11, 2015 | 17 | 2015 |
A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro K Rathore, M Cekanova Drug design, development and therapy, 5323-5335, 2015 | 17 | 2015 |
FK228 and oncogenic H-Ras synergistically induce Mek1/2 and Nox-1 to generate reactive oxygen species for differential cell death S Choudhary, K Rathore, HCR Wang Anti-cancer drugs 21 (9), 831-840, 2010 | 17 | 2010 |
Effects of environmental carcinogen benzo (a) pyrene on canine adipose-derived mesenchymal stem cells MC Kusum Rathore Research in Veterinary Science 103, 34-43, 2015 | 13 | 2015 |
Detection of carcinogen-induced bladder cancer by fluorocoxib A J Bourn, K Rathore, R Donnell, W White, MJ Uddin, L Marnett, ... BMC cancer 19, 1-13, 2019 | 6 | 2019 |
Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Des Devel Ther. 2014; 8: 1911–21 M Cekanova, K Rathore | 6 | |